LGND Ligand Pharmaceuticals Inc
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$1.60B
Revenue (FY)
$268.09M 2025-12-31
Net Income (FY)
$124.45M
P/E (float-based)
12.9
biopharmaceutical company based out of La Jolla, California.